GAMMA Investing’s Chemomab Therapeutics CMMB Stock Holding History

GAMMA Investing’s Portfolio CMMB Stock Details CMMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$10.9K	Buy	9,181 +4,441	+94%	+$9.1K	﹤0.01%	3279
2026 Q2	$7.68K	Sell	4,740 -2,839	-37%	-$4.78K	﹤0.01%	3313
2026 Q1	$11.9K	Buy	7,579 +5,065	+201%	+$8.65K	﹤0.01%	2979
2025 Q4	$4.15K	Buy	2,514 +1,847	+277%	+$4.9K	﹤0.01%	3360
2025 Q3	$1.75K	Sell	667 -2,536	-79%	-$9.35K	﹤0.01%	3486
2025 Q2	$14.9K	Buy	3,203 +446	+16%	+$2.21K	﹤0.01%	2613
2025 Q1	$12K	Buy	2,757 +1,482	+116%	+$10.4K	﹤0.01%	2662
2024 Q4	$9.23K	Buy	+1,275	New	+$8.05K	﹤0.01%	2656

Other funds holding CMMB

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

GAMMA Investing's CMMB Position: Q3 2026 in Review

GAMMA Investing increased its Chemomab Therapeutics (CMMB) stake by 94% in Q3 2026, buying an estimated $9.1K and bringing the position to 9,181 shares worth $10.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3279.

GAMMA Investing first reported a position in CMMB in Q4 2024 and has held it in 8 quarters since. The position peaked at $14.9K in Q2 2025. 2 funds tracked by Wall St. Rank hold CMMB as of Q3 2026.

GAMMA Investing held 9,181 shares of Chemomab Therapeutics worth $10.9K as of Q3 2026.
GAMMA Investing bought 4,441 Chemomab Therapeutics shares in Q3 2026, an estimated $9.1K.
Chemomab Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3279 holding.
GAMMA Investing first reported a position in Chemomab Therapeutics in Q4 2024 and has held it in 8 quarters since.
GAMMA Investing's Chemomab Therapeutics position peaked at $14.9K in Q2 2025.
2 funds tracked by Wall St. Rank held Chemomab Therapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.